Novo aims for GLP-1 sales growth in China
September 21, 2017Novo expects Victoza and semaglutide to gain momentum.
Diabetes
Novo highlights key ‘hypo’ data from Tresiba at EASD
September 15, 2017Novo hopes data will justify higher price compared with rival.
AZ talks up Bydureon data, GLP-1 and glucagon combo
September 14, 2017Novo showcases next-gen GLP-1 at EASD
September 13, 2017Semaglutide is under review in Europe and US.
Fitbit and Dexcom to bring diabetes data to Ionic smartwatch
September 8, 2017Dexcom G5 Mobile data will be displayed on Fitbit’s Ionic smartwatch.
FDA clears finger-prick free insulin pump-CGM combo
August 30, 2017Device combination capable of recommending treatment decisions without finger-pricking.
AZ looks to pay-for-performance to bolster cardio-diabetes franchise
August 17, 2017While many of the hopes and disappointments for AZ’s business are around oncology, it still needs its cardiovascular and diabetes portfolio to perform.
Pivotal study begins for algorithm-enhanced insulin pump
August 17, 2017Trial will test Tandem’s t:slim X2 pump alongside a predictive algorithm.
